Richard Shea
Director/Board Member at SYNLOGIC, INC.
Net worth: 930 $ as of 29/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Aoife Brennan | M | 48 |
Synlogic Operating Co., Inc.
 Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | 8 years |
| Michael Metzger | M | 53 | 9 years | |
| Nick Leschly | M | 51 |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | 8 years |
| Peter Barrett | M | 71 |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | 13 years |
| Michael Powell | M | 69 |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | 7 years |
| Mary Dooley | F | 43 | 6 years | |
| Ed Mathers Mathers | M | 64 |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | 12 years |
| Chau Khuong | M | 48 |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | 6 years |
| Michael Heffernan | M | 59 | 4 years | |
| Pierre Legault | M | 63 | 7 years | |
| William Meury | M | 56 | 6 years | |
| Luke Albrecht | M | 45 | 8 years | |
| James Collins | M | 58 |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | 10 years |
| Timothy Lu | M | 43 |
Synlogic Operating Co., Inc.
Synlogic Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Synlogic Operating Co., Inc. operates as a biopharmaceutical company. The firm's pipeline focuses on rare diseases, the company is leveraging the broad potential of its synthetic biotics platform for novel drug development in major disease areas through partnerships with pharmaceutical and biotechnology companies. It also engages in development of synthetic biotics-based treatment for inflammatory bowel disease. The company was founded by James J. Collins and Timothy K. Lu in 2014 and is headquartered in Cambridge, MA. | 10 years |
| Jennifer Jarrett | F | 53 | 6 years | |
| Thomas J. Adam | M | - | 7 years | |
| Brendan St Amant | M | - | 3 years | |
| Keith Katkin | M | 52 | 7 years | |
| Jo-Ann Beltramello | F | - | 17 years | |
| Molly Harper | F | 48 | 3 years | |
| Caroline Kurtz | M | - | 8 years | |
| Anjali Ganguli | M | 48 | 9 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jose-Carlos Gutiérrez-Ramos | M | 61 | 5 years | |
| Craig Wheeler | M | 63 | 14 years | |
| Allan Shaw | M | 59 | 1 years | |
| Antoine Awad | M | 44 | 6 years | |
| Briggs Morrison | M | 65 | 9 years | |
| John S. Pallies | M | 60 | 9 years | |
| Alexander Nolte | M | 52 | 6 years | |
| Jay Mohr | M | - |
Variagenics, Inc.
 Variagenics, Inc. Miscellaneous Commercial ServicesCommercial Services Variagenics, Inc. develops molecular diagnostic tests by identifying genetic markers associated with response to cancer therapies, with the goal of optimizing patient care through both biopharmaceutical collaborations and its own internal research programs | 2 years |
| Leonard Patrick Gage | M | 81 |
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 9 years |
| Bruce Downey | M | 76 | 11 years | |
| Arlene Morris | F | 72 | 4 years | |
| Christoph Westphal | M | 56 | 5 years | |
| Todd Shegog | M | 59 | 3 years | |
| Thomas Paul Koestler | M | 72 | 9 years | |
| Young Kwon | M | 52 | 10 years | |
| Ivor Royston | M | 79 | 4 years | |
| Corey Fishman | M | 59 | 4 years | |
| Steven Gilman | M | 71 | 4 years | |
| Luke Evnin | M | 60 | 6 years | |
| George W. Sledge | M | 73 | 3 years | |
| Elizabeth Stoner | M | 73 | 13 years | |
| Kim Kamdar | M | 56 | 11 years | |
| Ben Shapiro | M | 84 | 13 years | |
| Ram Sasisekharan | M | 58 | 9 years | |
| Michael Meyers | M | 74 | 7 years | |
| Robert Langer | M | 74 | 8 years | |
| Henry Chen | M | 53 | 3 years | |
| Michael Burgess | M | 61 | 4 years | |
| Marsha Fanucci | F | 70 | 11 years | |
| Bruce A. Leicher | M | 68 | 10 years | |
| Peter Hutt | M | 89 | 13 years | |
| Scott M. Storer | M | - | 2 years | |
| John Clarke | M | 70 | 13 years | |
| James Sulat | M | 73 | 11 years | |
| Lisa Kelly-Croswell | F | 57 | 3 years | |
| Lisa Carron Shmerling | F | 63 | - | |
| Patricia Hurter | M | 60 | 5 years | |
| Georges Gemayel | M | 63 | 4 years | |
| Philip Nickson | M | 45 | 9 years | |
| Robert D. Ciappenelli | M | 57 | 2 years | |
| Michael Morneau | M | 58 | 2 years | |
| Takashi Kishimoto | M | 64 | 5 years | |
| Anthony Manning | M | 62 | - | |
| Steven Fruchtman | M | 73 | 1 years | |
| Narinder Singh | M | 51 | 3 years | |
| Scott Plevy | M | - | - | |
| Jan Hillson | M | 71 | 3 years | |
| Alex Fotopoulos | M | 55 | 5 years | |
| Eric Shaff | M | 48 | 2 years | |
| Matthew P. Ottmer | M | 53 | 2 years | |
| Daniel Rosan | M | - | 1 years | |
| John W. Loewy | M | - |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 5 years |
| Thomas Spitznagel | M | 57 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 4 years |
| Dean A. Falb | M | 63 | 5 years | |
| Zoltan A. Csimma | M | 82 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 10 years |
| Garen Bohlin | M | 76 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 14 years |
| Karen Dawes | F | 72 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 4 years |
| Steven B. Brugger | M | 65 | 8 years | |
| John Bishop | M | 62 | 12 years | |
| Elizabeth A. Olek | M | 59 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 4 years |
| Ramani Varanasi | F | 54 | - | |
| John L. Zabriskie | M | 85 | - | |
| Gabriel Schmergel | M | 83 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 15 years |
| Paul S. Miller | M | 65 | - | |
| Jeffrey S. Stubbs | M | 61 | - | |
| Gary Hattersley | M | 57 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 8 years |
| Robert H. Tidwell | M | 80 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 5 years |
| Gregg Beloff | M | 56 | 3 years | |
| Catharine E. Johnson | M | - | - | |
| Stephen T. Reeders | M | 70 | 5 years | |
| Stephen Albert Martin | M | 54 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 5 years |
| Adelene Perkins | F | 54 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 7 years |
| John L. Knopf | M | 71 |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 16 years |
| Daphne Karydas | F | 49 | 1 years | |
| Paul David Goldenheim | M | - | - | |
| James M. Roach | M | 64 | 8 years | |
| Michael F. Jarvis | M | - |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | 8 years |
| Jun Lu | M | 58 | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Richard Shea
- Personal Network
